Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study
Endocrinology, Diabetes & Metabolism · 2026
DOI: 10.1002/edm2.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Behnaz Abiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti Universit…. Hauptthemen laut MEDLINE: Obesity, Fatty Liver, Obesity, Metabolically Benign. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Uncertainty surrounds the relationship between metabolic decline and fatty liver disease. The purpose of this study was to evaluate the effect of hepatic steatosis (HS) on the transition from metabolically healthy obesity (MHO) to metabolically unhealthy obesity (MUO) and to determine whether the Fatty Liver Index (FLI) can predict this progression.
Methods
In this prospective cohort research, participants in the Tehran Lipid and Glucose Study (TLGS) comprised 593 MHO adults who were at least 40 years old at baseline. The subjects were followed up for a period of 12 years to see if the subjects' metabolically healthy obesity phenotype changed to an unhealthy one. The body mass index (BMI) of 30.0 kg/m 2 was used to characterise obesity. The concept of metabolically healthy (less than two variables) or metabolically abnormal (two or more) was based on four metabolic parameters: low high density lipoprotein‐cholesterol (HDL‐c) concentration, hypertension, hypertriglyceridemia, and impaired fasting glucose. The technique used to construct the fatty liver index (FLI), which serves as an indication of HS, was based on waist circumference (WC), triglycerides, BMI, and gamma‐glutamyl transferase.
Results
During a median of 4.81 years of follow‐up (interquartile range 1.75–10.74 years), 72.2% ( n = 428) of MHO individuals transitioned to the MUO phenotype. Transitioning participants exhibited higher FLI scores, BMI, waist circumference, and unfavourable metabolic profiles compared to non‐transitioning participants. Cox regression analysis revealed that hepatic steatosis (HR: 1.369; 95% CI: 1.014–1.848), lower physical activity (HR: 1.267; 95% CI: 1.035–1.551), and a higher TyG index (HR: 3.208; 95% CI: 1.546–6.657) were significant predictors of transition to MUO.
Conclusion
Hepatic steatosis at baseline is an independent risk factor for progression from metabolically healthy status to metabolically abnormal phenotype in obese individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obesity Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.
Zitieren
APA
Abiri, B., Nikoohemmat, M., Mahdavi, M., Ahmadi, A. R., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2026). Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70156
Vancouver
Abiri B, Nikoohemmat M, Mahdavi M, Ahmadi AR, Valizadeh M, Azizi F, et al. Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70156
BibTeX
@article{Abiri2026,
author = {Abiri, Behnaz and Nikoohemmat, Mohammad and Mahdavi, Maryam and Ahmadi, Amirhossein Ramezani and Valizadeh, Majid and Azizi, Fereidoun and Hosseinpanah, Farhad},
title = {Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
doi = {10.1002/edm2.70156}
}
EUVIMED